Mipomersen Sodium
CAS 1000120-98-8Nucleotide
Overview
Mipomersen Sodium is an antisense oligonucleotide inhibitor designed to reduce low-density lipoprotein (LDL) cholesterol levels. It achieves this by inhibiting the synthesis of apolipoprotein B-100, which is a core component of LDL and very low-density lipoprotein (VLDL).
Therapeutic areas
CardiovascularLipid metabolism disorders
Verified Supplier Partner
Do you supply Mipomersen Sodium? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.